Amerise Biosciences Share Price Today | Stock Price & Amerise Biosciences Share Screener
As of October 16, 2026, the live Amerise Biosciences share price (BSE: AMERISE) is ₹0.84, unchanged from the previous close, with shares trading between ₹0.80 and ₹0.85 in today's trading session, and a 52-week range of ₹0.50–₹1.01. Check AMERISE price range for the annual price range and momentum. Use the Amerise Biosciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Amerise Biosciences opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Amerise Biosciences Share Price Chart
Track the current stock price of Amerise Biosciences with an interactive chart. Analyse AMERISE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Amerise Biosciences stock quote in one place.
The quote of ₹0.84 sits between the 52-week low of ₹0.50 and the 52-week high of ₹1.01.
Amerise Biosciences Company Profile - Fundamental Screener
Screen Amerise Biosciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AMERISE shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Industrial Products sector and the Plastic Products - Industrial industry, and it trades under ISIN INE673C01020.
Company Details
Classification
Identifiers and Leadership
Amerise Biosciences Balance Sheet Screener
Screen AMERISE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹7, down from ₹9 in 2025.
Latest statistics put total assets at ₹7 and shareholder funds at ₹5.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 7 | 9 | 5 | 6 | 12 | 6 | 6 | 6 | 6 | 6 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 5 | 5 | 5 | 6 | 6 | 5 | 5 | 6 | 6 | 6 |
| Share Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | -1 | -1 | -1 | -1 | -1 | -2 | -1 | -1 | -1 | -1 |
Amerise Biosciences Income Statement Screener - Profit & Revenue Analysis
Screen Amerise Biosciences income statement and profit fundamentals. Analyze AMERISE quarterly results. Amerise Biosciences reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹0 and net profit of ₹0.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 9 | 0 | 0 | 1 | 0 | 1 | 0 | 0 |
Operating Costs and Margins | |||||||||||||
| EBITDA | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
| Operating Profit % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
| EPS | 0.00 | 0.00 | 0.00 | -0.02 | -0.02 | 0.08 | -0.05 | -0.02 | 0.00 | 0.00 | -0.14 | 0.00 | -0.01 |
Amerise Biosciences Cash Flow Screener - Liquidity Fundamentals
Screen AMERISE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹1, and net cash flow was an inflow of ₹1.
Over the same period, investing activities provided ₹2 and financing activities provided ₹0.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | -1 | 3 | 0 | 0 | 0 | 0 | 5 | -2 | 0 | -4 |
| Investing Activities | 2 | -3 | 0 | 0 | 0 | 0 | -5 | 2 | 0 | 4 |
Financing and Net Cash | ||||||||||
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Amerise Biosciences Shareholding Pattern Screener
See Amerise Biosciences shareholding pattern with promoter, FII, and DII holdings. Check Amerise Biosciences promoter holding and ownership changes for AMERISE on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 0.00%, foreign institutions 0.00%, domestic institutions 0.00% and the public 71.97%, spread across 34,519 shareholders.
The shareholder count was 34,519 in 2026-Mar, compared with 33,848 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2026-Sept | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 71.97% | 69.90% | 67.49% | 72.09% | 72.04% | 72.04% | 72.01% | 72.32% |
| Other Holding | 28.03% | 30.10% | 32.51% | 27.91% | 27.96% | 27.96% | 27.99% | 27.68% |
| Shareholder Count | 34,519 | 33,848 | 33,026 | 36,595 | 36,217 | 35,676 | 35,180 | 23,485 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Amerise Biosciences. Amerise Biosciences dividend yield can be compared with peers and other stocks in the market.
Amerise Biosciences Stock Index Membership - Nifty & Sensex
See which indices include Amerise Biosciences stock. Check AMERISE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Amerise Biosciences Market Events Screener - Corporate Actions
Get Amerise Biosciences corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Amerise Biosciences stock events that may affect AMERISE share price, along with derivatives, futures and options activity and sector gainers.
12 corporate actions are listed, the most recent entry being Annual General Meeting dated September 24, 2026, with a record date of September 24, 2026.
It is followed by Quarterly Result Announcement dated August 3, 2026 and Quarterly Result Announcement dated May 5, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-24 | 2026-09-24 | Annual General Meeting | NA | 0.00% |
| 2026-08-03 | 2026-08-03 | Quarterly Result Announcement | NA | 14.77% |
| 2026-05-05 | 2026-05-05 | Quarterly Result Announcement | NA | 1.41% |
| 2026-02-02 | 2026-02-02 | Quarterly Result Announcement | NA | -6.15% |
| 2025-11-05 | 2025-11-05 | Quarterly Result Announcement | NA | -3.03% |
| 2025-09-23 | 2025-09-23 | Annual General Meeting | NA | -9.09% |
| 2025-07-24 | 2025-07-24 | Quarterly Result Announcement | NA | -5.06% |
| 2025-05-19 | 2025-05-19 | Quarterly Result Announcement | NA | 1.27% |
| 2025-02-03 | 2025-02-03 | Quarterly Result Announcement | NA | -7.27% |
| 2024-10-22 | 2024-10-22 | Quarterly Result Announcement | NA | 2.33% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | 0.00% |
| 2021-08-16 | 2021-08-16 | Change Of Name | NA | 0.00% |
Amerise Biosciences Competitors Screener - Peer Stocks Comparison
Screen AMERISE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Industrial Products sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Supreme Industries | 45,993 | 44.32 | 11,263 | 7.22% | 954 | 58.62 |
| Astral | 38,363 | 66.96 | 6,616 | 12.64% | 535 | 51.28 |
| Garware Hi-Tech Films | 16,164 | 41.72 | 2,185 | 0.98% | 338 | 50.66 |
| Shaily Engineering Plastics | 14,282 | 80.80 | 998 | 26.52% | 170 | 47.57 |
| Finolex Industries | 9,388 | 15.48 | 4,325 | -1.45% | 599 | 44.53 |
| Kingfa Science & Technology | 8,680 | 39.25 | 2,016 | 14.94% | 185 | 50.37 |
| Time Technoplast | 8,596 | 17.80 | 6,114 | 11.94% | 477 | 38.71 |
| Prince Pipes & Fittings | 3,065 | 30.58 | 2,609 | 2.82% | 75 | 57.78 |
| Apollo Pipes | 2,283 | -159.65 | 1,115 | -6.03% | 5 | 43.93 |
| Jain Irrigation Systems | 1,903 | -27.93 | 6,413 | 10.70% | -40 | 38.54 |
Amerise Biosciences Company Announcements - News & Reports Screener
Screen AMERISE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 10, 2026.
The next most recent announcements are dated October 6, 2026 and September 24, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-10 | Updation In The Website Of The Company. | - |
| 2026-10-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-09-24 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-24 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-17 | Closure of Trading Window | - |
| 2026-09-01 | Reg. 34 (1) Annual Report. | - |
| 2026-09-01 | Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-09-01 | Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-18 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-03 | Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") | - |
| 2026-08-03 | Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") | - |
| 2026-08-03 | Board Meeting Outcome for Outcome Of Board Meeting Held On 3Rd August 2026 | - |
| 2026-07-29 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-22 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-21 | Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting. | - |
| 2026-07-17 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-17 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-09 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-11 | Closure of Trading Window | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹0.84, within a 52-week range of ₹0.50 to ₹1.01. The P/B ratio is 1.03. Market capitalisation stands at ₹5.40 Cr. The company operates in the Industrial Products sector, in the Plastic Products - Industrial industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 19, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.